Cancer Institute Frustrated with Leadership

Researchers responding to a survey at MD Anderson Cancer Center report low morale due to their president’s leadership style.

Written byEdyta Zielinska
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The eastern part of the UT MD Anderson campusWIKIMEDIA, NIGHTRYDER84 About a third of the MD Anderson Cancer Center’s faculty responded to a survey expressing concern over changes at the institute that include president Ron DePinho’s “dictatorial” style and the departure of more nurturing leadership. The results of the survey were published last week (March 29) in The Cancer Letter.

Approximately 70 percent of respondents said that faculty morale was worse than it was in 2010, citing leadership that was unresponsive to its staff, “top heavy,” and “inefficient.” Events that have been particularly distressing include DePinho’s conflict of interest issues, such as promoting the stock of a company that he co-founded without first disclosing his involvement, as well as the fact that his wife was considered for an $18 million grant for an institute he founded by the beleaguered Cancer Prevention and Research Institute of Texas (CPRIT) without scientific review. One respondent wrote of being “so tired of having to answer questions from other Houstonians about why MD Anderson is going downhill,” according to a Nature blog.

However, it is unclear how widespread the dissatisfaction ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies